These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 26255220

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. D-leucine microparticles as an excipient to improve the aerosolization performances of dry powders for inhalation.
    Schoubben A, Vivani R, Paolantoni M, Perinelli DR, Gioiello A, Macchiarulo A, Ricci M.
    Eur J Pharm Sci; 2019 Mar 15; 130():54-64. PubMed ID: 30677523
    [Abstract] [Full Text] [Related]

  • 5. Capreomycin inhalable powders prepared with an innovative spray-drying technique.
    Schoubben A, Giovagnoli S, Tiralti MC, Blasi P, Ricci M.
    Int J Pharm; 2014 Jul 20; 469(1):132-9. PubMed ID: 24747443
    [Abstract] [Full Text] [Related]

  • 6. Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resistant tuberculosis.
    Momin MAM, Sinha S, Tucker IG, Das SC.
    Drug Dev Ind Pharm; 2019 Aug 20; 45(8):1321-1331. PubMed ID: 31014129
    [Abstract] [Full Text] [Related]

  • 7. Simple and scalable method for peptide inhalable powder production.
    Schoubben A, Blasi P, Giovagnoli S, Ricci M, Rossi C.
    Eur J Pharm Sci; 2010 Jan 31; 39(1-3):53-8. PubMed ID: 19879945
    [Abstract] [Full Text] [Related]

  • 8. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y, Zhao M, Liu G, Tang X.
    J Pharm Pharmacol; 2007 Jul 31; 59(7):927-34. PubMed ID: 17637186
    [Abstract] [Full Text] [Related]

  • 9. Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization.
    Jong T, Li J, Morton DA, Zhou QT, Larson I.
    J Pharm Sci; 2016 Mar 31; 105(3):1156-63. PubMed ID: 26886330
    [Abstract] [Full Text] [Related]

  • 10. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
    Yu J, Chan HK, Gengenbach T, Denman JA.
    Eur J Pharm Biopharm; 2017 Oct 31; 119():224-234. PubMed ID: 28655664
    [Abstract] [Full Text] [Related]

  • 11. Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation.
    Fabio K, Curley K, Guarneri J, Adamo B, Laurenzi B, Grant M, Offord R, Kraft K, Leone-Bay A.
    AAPS PharmSciTech; 2015 Dec 31; 16(6):1299-306. PubMed ID: 25776985
    [Abstract] [Full Text] [Related]

  • 12. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.
    Eedara BB, Tucker IG, Das SC.
    Int J Pharm; 2016 Jun 15; 506(1-2):174-83. PubMed ID: 27091294
    [Abstract] [Full Text] [Related]

  • 13. Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections.
    Vandenheuvel D, Singh A, Vandersteegen K, Klumpp J, Lavigne R, Van den Mooter G.
    Eur J Pharm Biopharm; 2013 Aug 15; 84(3):578-82. PubMed ID: 23353012
    [Abstract] [Full Text] [Related]

  • 14. Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device.
    Kim KS, Kim JH, Jin SG, Kim DW, Kim JO, Yong CS, Youn YS, Oh KT, Woo JS, Choi HG.
    Pharm Dev Technol; 2018 Feb 15; 23(2):158-166. PubMed ID: 28612675
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.
    Son YJ, Worth Longest P, Hindle M.
    Int J Pharm; 2013 Feb 25; 443(1-2):137-45. PubMed ID: 23313343
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW, Schneider M, Morrical BD, Imanidis G.
    J Pharm Sci; 2018 Apr 25; 107(4):984-998. PubMed ID: 29247741
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.